FDA product code GMD: Antisera, Latex Agglutination, Cryptococcus Neoformans
GMD is the FDA product code for antisera, latex agglutination, cryptococcus neoformans. It is a Class II device, regulated under 21 CFR 866.3165 and reviewed by the Microbiology panel. FDA has cleared 10 510(k) submissions under GMD, from 6 different applicants. The average 510(k) review took 121 days (median 32). FDA has posted 3 recalls for GMD devices, 1 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Antisera, Latex Agglutination, Cryptococcus Neoformans |
| Device class | Class II |
| Regulation | 21 CFR 866.3165 |
| Review panel | MI — Microbiology |
| Medical specialty | Microbiology |
| Premarket route | 510(k) exempt |
Compare with all 510(k) review times · Search every GMD clearance
Top GMD applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Immuno-Mycologics, Inc. | 4 | 2012-03-28 |
| Meridian Diagnostics, Inc. | 2 | 1989-09-08 |
| Trinity Laboratories, Inc. | 1 | 1994-02-17 |
| Alexon Biomedical, Inc. | 1 | 1993-11-22 |
| American Scientific Products | 1 | 1981-08-31 |
1 more applicants have GMD clearances. See the full list in Caduvo.
Most recent GMD clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K112422 | Immuno-Mycologics, Inc. | CRAG LATERAL FLOW ASSAY (LFA) | 2012-03-28 | 218 |
| K102286 | Immuno-Mycologics, Inc. | CRAG LATERAL FLOW ASSAY (CRAG LFA) | 2011-07-20 | 342 |
| K930418 | Trinity Laboratories, Inc. | CRYPTO-LEX SYSTEM | 1994-02-17 | 387 |
| K933997 | Alexon Biomedical, Inc. | PROSPECT ENTAMOEBA HISTOLYTICA MICROPLATE ASSAY | 1993-11-22 | 97 |
| K894845 | Meridian Diagnostics, Inc. | (CALAS(TM)) W/ADD'L REAGENT CALAS(TM) PRONASE | 1989-09-08 | 28 |
Recalls for GMD devices
3 product recalls in 3 recall events; 1 initiated in the last five years and 0 still open. Most recent: 2022-01-03.
| Year | Recalls |
|---|---|
| 2018 | 1 |
| 2022 | 1 |
Frequently asked questions
What is FDA product code GMD?
GMD is the FDA product code for antisera, latex agglutination, cryptococcus neoformans. It is a Class II device, regulated under 21 CFR 866.3165 and reviewed by the Microbiology panel.
What device class is GMD?
Class II, regulation 21 CFR 866.3165. Typical premarket route: 510(k) exempt.
How long does a 510(k) take for product code GMD?
Across 10 cleared submissions the average was 121 days from receipt to decision (median 32).
Which companies have the most GMD clearances?
Immuno-Mycologics, Inc. (4); Meridian Diagnostics, Inc. (2); Trinity Laboratories, Inc. (1); Alexon Biomedical, Inc. (1); American Scientific Products (1).
Have GMD devices been recalled?
Yes: 3 product recalls across 3 recall events; the most recent began 2022-01-03.
Next steps
- Run an FDA pathway report with predicate devices for product code GMD
- Run a recall and safety report across every GMD manufacturer
- Watch product code GMD for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times